Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: LEG, POL, AVO

OCHIN Applauds Critical Updates to 42 CFR Part 2 in CARES Act


PORTLAND, Ore., March 27, 2020 /PRNewswire/ -- OCHIN strongly supports the long-term updates that were made to 42 CFR Part 2 as part of the larger CARES Act that Congress passed in response to the COVID-19 crisis. The new rule closes an important gap in our nation's health care system by aligning the laws that govern substance use records with existing HIPAA laws that regulate the exchange of medical records between providers, with informed patient consent.

We believe this change will vastly improve health care coordination, ensuring that the patients who receive behavioral health treatment across the OCHIN network of providers have access to the best possible care.

We are profoundly grateful for all the hard work that's been done to craft this new rule, including the leadership of Senators Shelley Moore Capito (R-WV) and Joe Manchin (D-WV), Congressmen Earl Blumenauer (D-OR) and Markwayne Mullin (R-OK), and the entire Partnership to Amend 42 CFR Part 2 coalition, of which OCHIN is also a member. We are highly encouraged by this legislative milestone, and what it means for the health and safety of the underserved communities that OCHIN champions.

About OCHIN
OCHIN is dedicated to creating a healthier future in every community. A national nonprofit health IT organization with a 20-year history, OCHIN brings advanced technology, research and services to underserved areas, both urban and rural. A driving force for health equity, OCHIN empowers community health organizations serving lower-income areas so that they can deliver the highest quality care to their patients. Learn more at www.ochin.org.

Contact: Jennifer Stoll, 503-720-9882, [email protected]

SOURCE OCHIN


These press releases may also interest you

at 12:32
The countdown has begun for Northern Colorado's most exhilarating fitness competition of the year as "Health4Heroes" gears up to host its highly anticipated 3rd Annual Military and First Responder-inspired "Guardian Games & Expo" on Saturday, May 18,...

at 12:06
A Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum products was responsible for a former service station...

at 12:05
Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today presented results from new preclinical research demonstrating production of active ALP by a BCM, which highlights BCMs as a...

at 11:50
EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Pejvack Motlagh MD, MSc, as Chief...

at 11:30
WomenHeart: The National Coalition for Women with Heart Disease, in collaboration with Bayer, is proud to announce the launch of the Understanding Her Heart: Women and Cardiovascular Disease initiative. This groundbreaking partnership aims to bolster...

at 11:15
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of results from SLIM LIVER (also known as A5371) in the Annals of Internal Medicine. "The Effect of Open-Label Semaglutide on...



News published on and distributed by: